文献速递皮肤肿瘤

反射式共聚焦显微镜在莫氏手术前确认活检后临床阴性部位残留基底细胞癌的前瞻性研究

Reflectance confocal microscopy confirms residual basal cell carcinoma on clinically negative biopsy sites before Mohs micrographic surgery: A prospective study.
PubMed 文献 · J Am Acad Dermatol · 2019-06-19

该前瞻性研究纳入61例活检证实基底细胞癌且临床无残留肿瘤证据、拟行莫氏手术的患者,术前行手持反射式共聚焦显微镜(RCM)评估。RCM阳性率73.8%,组织病理残留BCC为68.9%;RCM敏感度92.8%、特异度68.4%、阳性预测值86.6%、阴性预测值81.2%。排除5例高危亚型后敏感度与阴性预测值均达100%。

要点

  • RCM对活检后临床阴性部位残留BCC的敏感度为92.8%、特异度为68.4%。
  • RCM可漏诊高危、浸润性及基底鳞状细胞癌亚型。
  • 排除高危亚型后RCM敏感度与阴性预测值均达100%。

核心结论

  • RCM是评估活检后残留BCC的有价值工具,有望减少不必要的手术。

研究设计与样本

  • 前瞻性研究纳入61例活检证实BCC且临床无残留肿瘤证据、拟行莫氏手术的连续患者,术前行手持RCM成像。

主要发现

  • 61例患者平均年龄61.7岁(标准差12.2岁,范围37-87岁),60.7%为女性。
  • 平均病灶大小5.1 mm(范围3-12 mm),RCM阳性73.8%,组织病理残留BCC为68.9%。
  • RCM敏感度92.8%、特异度68.4%、阳性预测值86.6%、阴性预测值81.2%。
  • 3例BCC被RCM漏诊,分别为高危、浸润性和基底鳞状细胞癌。
  • 排除5例高危亚型后,敏感度和阴性预测值均为100%。

临床怎么用

  • 可用于活检后临床阴性部位残留BCC的术前评估,辅助决定是否行莫氏手术。
  • 对高危亚型需谨慎,RCM可能漏诊深部残留肿瘤。

局限性

  • RCM可能漏诊深部残留肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biopsy specimens from patients with basal cell carcinoma (BCC) can present to surgery with no clinically residual tumor, complicating treatment decisions. OBJECTIVE: To evaluate reflectance confocal microscopy (RCM) for the assessment of residual BCC following biopsy. METHODS: Consecutive patients with biopsy-proven BCC and no clinical evidence of residual tumor who had been referred for Mohs micrographic surgery were included. Biopsy sites were imaged with a handheld RCM device. On the basis of RCM evaluation, cases were labeled RCM positive or RCM negative. Mohs micrographic surgery was performed in all cases; margins and 15-μm serial vertical sectioning were evaluated. RESULTS: A total of 61 patients were included (mean age, 61.7 years [standard deviation, 12.2 years]; range, 37-87 years); 60.7% were women. The mean lesion size was 5.1 mm (range, 3-12 mm); 73.8% of patients were positive on RCM, and 68.9% had residual BCC on histopathologic examination. The rates of RCM sensitivity, specificity, positive predictive value, and negative predictive value were 92.8%, 68.4%, 86.6%, and 81.2%, respectively. Three cases of BCC (high-risk, infiltrative, and basosquamous) were missed with use of RCM. When high-risk subtypes were excluded (n = 5), sensitivity and negative predictive value were both 100%. LIMITATIONS: RCM can miss deep-seated residual tumor. CONCLUSION: RCM is a valuable tool for the evaluation of residual BCC following biopsy, with the potential to reduce unnecessary surgical procedures.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Navarrete-Dechent C, Cordova M, Aleissa S, et al. Reflectance confocal microscopy confirms residual basal cell carcinoma on clinically negative biopsy sites before Mohs micrographic surgery: A prospective study. J Am Acad Dermatol. 2019. PMID: 31227277. doi:10.1016/j.jaad.2019.02.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。